Optomed Plc Company Announcement November 13, 2024 11.00 am EEST
Share subscriptions based on stock options 2018C
A total of 62,900 Optomed Plc's new shares has been subscribed for with the
company's stock options 2018C on 25 October 2024.
For subscriptions made with the stock options 2018C the entire subscription
price of EUR 220,150.00 will be entered in the reserve for invested unrestricted
equity.
After the trade registration, the total number of shares is 19,693,297.
The shares subscribed for under the stock options 2018C have been registered in
the Trade Register on 13 November 2024, as of which date the new shares will
establish shareholder rights.
The shares will be traded on the main list of Nasdaq Helsinki Ltd together with
the old shares as of 14 November 2024.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld cameras with software and
artificial intelligence with the aim to transform the diagnostic process of
blinding eye diseases such as rapidly increasing diabetic retinopathy. In its
business Optomed focuses on eye screening devices and software solutions related
R&D in Finland and sales through different channels in over 60 countries.
www.optomed.com